Enhancing the predictability of drug toxicity and efficacy

There is an unmet clinical need in drug development for in vitro models that reduce the risk of drug-induced toxicity and late-stage drug attrition.

In this webinar, hosted on May 26 2021, two expert speakers discuss how researchers can enhance the predictability of pre-clinical drug development.

This webinar, Enhancing the predictability of preclinical development, hosted by DDW and supported by PerkinElmer, took place on 26 May.

Dr. Seyoum Ayehunie, Vice President, Scientific Research and Development, MatTek Corporation, will discuss the functionality and limitations of a novel in vitro 3D primary human cell-based tissue model for drug toxicity and efficacy studies.

This talk will be followed by a presentation from Dr. Hyelim Cho, Group Lead, Immunogenicity, Global DMPK Oncology and Rare Diseases, Takeda Pharmaceuticals, (pictured),  who will explain why developing a predictive pre-clinical assay is key to success in immuno-oncology drug development.

Key Learning Objectives:

  • How to evaluate models to establish robust and reliable preclinical investigation of drug candidates prior to entering clinical trials
  • How to gain an understanding of the advancements in preclinical model systems and assays
  • What to consider from the latest innovations and impact on bioanalytical assays

Who Should Attend:

  • Preclinical development scientists
  • Pharmacologists
  • Toxicologists
  • Bioanalytical assay development scientists
  • Analytical scientists

Watch on demand for free here.


Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free